The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Growth Factors and Cancer
Abstract
Signaling pathways that mediate the normal functions of growth factors are commonly subverted in cancer. Oncogenes identified by a variety of approaches have been shown to function at critical steps in mitogenic signaling. Progression through the cell cycle requires the coordinated actions of members of two complementary classes of growth factors, and oncogenes appear to replace the actions of one set of these growth factors. Growth factors can also influence normal cell differentiation, and constitutive activation of growth-promoting pathways in cancer cells can modulate the cell phenotype as well. Paracrine actions of growth factors and cytokines may also influence the stepwise series of genetic events that lead to malignancy. New approaches for cancer therapy are being developed that intervene at various steps in growth factor signaling pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Inositol phosphates and cell signalling
Berridge, M. J., & Irvine, R. F. (1989) · Nature · doi:10.1038/341197a0 · Cited by 4,058
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
The p53 tumour suppressor gene
Levine, A. J., Momand, J., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,788
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Cited by
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2639 · Cited by 2,765
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
Epidermal growth factor receptor (EGFR) signaling in cancer
Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M. R., Carotenuto, A., De Feo, G., Caponigro, F., & Salomon, D. S. (2006) · Gene · doi:10.1016/j.gene.2005.10.018 · Cited by 2,038
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., & Mayer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.182 · Cited by 1,694
Emergent Properties of Networks of Biological Signaling Pathways
Bhalla, U. S., & Iyengar, R. (1999) · Science · doi:10.1126/science.283.5400.381 · Cited by 1,686
Baselga, J., Tripathy, D., Mendelsohn, J., Baughman, S., Benz, C. C., Dantis, L., Sklarin, N. T., Seidman, A. D., Hudis, C. A., Moore, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.737 · Cited by 1,380
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Edwards, D. R., Murphy, G., Reynolds, J. J., Whitham, S. E., Docherty, A. J., Angel, P., & Heath, J. K. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02449.x · Cited by 1,221
Mohammadi, M., McMahon, G., Sun, L., Tang, C., Hirth, P., Yeh, B. K., Hubbard, S. R., & Schlessinger, J. (1997) · Science · doi:10.1126/science.276.5314.955 · Cited by 1,097
Gallbladder cancer: epidemiology and outcome
Shaffer, E., & Hundal, R. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37357 · Cited by 1,089
Kulik, G., Klippel, A., & Weber, M. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1595 · Cited by 1,040
Identification of Heregulin, a Specific Activator of p185 erbB2
Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., et al. (1992) · Science · doi:10.1126/science.256.5060.1205 · Cited by 962
Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
Giovannucci, E. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3109s · Cited by 959
Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens
Olivera, A., & Spiegel, S. (1993) · Nature · doi:10.1038/365557a0 · Cited by 889
Giovannucci, E. (1995) · Cancer Causes and Control · doi:10.1007/bf00052777 · Cited by 817
Wells, A. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00015-1 · Cited by 817
Nusse, R., & Varmus, H. E. (1992) · Cell · doi:10.1016/0092-8674(92)90630-u · Cited by 815
A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., & Bridges, A. J. (1994) · Science · doi:10.1126/science.8066447 · Cited by 806
Schweigerer, L., Neufeld, G., Friedman, J., Abraham, J. A., Fiddes, J. C., & Gospodarowicz, D. (1987) · Nature · doi:10.1038/325257a0 · Cited by 754
Baselga, J., Pfister, D., Cooper, M. R., Cohen, R., Burtness, B., Bos, M., D’Andrea, G., Seidman, A., Norton, L., Gunnett, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.904 · Cited by 741
Plowman, G. D., Culouscou, J. M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G., & Shoyab, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1746 · Cited by 713
O'Hara, P. J., Sheppard, P. O., Thógersen, H., Venezia, D., Haldeman, B. A., McGrane, V., Houamed, K. M., Thomsen, C., Gilbert, T. L., & Mulvihill, E. R. (1993) · Neuron · doi:10.1016/0896-6273(93)90269-w · Cited by 709
Skolnik, E. Y., Lee, C. H., Batzer, A., Vicentini, L. M., Zhou, M., Daly, R., Myers, M. J., Backer, J. M., Ullrich, A., & White, M. F. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05842.x · Cited by 694
Growth factors in development, transformation, and tumorigenesis
Cross, M., & Dexter, T. M. (1991) · Cell · doi:10.1016/0092-8674(91)90638-f · Cited by 694
Ip, N. Y., Nye, S. H., Boulton, T. G., Davis, S., Taga, T., Li, Y., Birren, S. J., Yasukawa, K., Kishimoto, T., Anderson, D. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90634-o · Cited by 684
Napoli, C., Glass, C. K., Witztum, J. L., Deutsch, R., D'Armiento, F. P., & Palinski, W. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02131-5 · Cited by 645
The Role of Adiponectin in Cancer: A Review of Current Evidence
Dalamaga, M., Diakopoulos, K. N., & Mantzoros, C. S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1015 · Cited by 640
Structure and Function of Human Amphiregulin: A Member of the Epidermal Growth Factor Family
Shoyab, M., Plowman, G. D., McDonald, V. L., Bradley, J. G., & Todaro, G. J. (1989) · Science · doi:10.1126/science.2466334 · Cited by 597
Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Levy, R. B., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90456-m · Cited by 577
Herbst, R. S., Maddox, A.-M., Rothenberg, M. L., Small, E. J., Rubin, E. H., Baselga, J., Rojo, F., Hong, W. K., Swaisland, H., Averbuch, S. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.038 · Cited by 572
Estrogenic Regulation of Growth and Polypeptide Growth Factor Secretion in Human Breast Carcinoma
DICKSON, R. B., & LIPPMAN, M. E. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-1-29 · Cited by 568
Pischon, T., Lahmann, P. H., Boeing, H., Friedenreich, C., Norat, T., Tjønneland, A., Halkjaer, J., Overvad, K., Clavel-Chapelon, F., Boutron-Ruault, M.-C., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj246 · Cited by 554
Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., & Baserga, R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3604 · Cited by 538
TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest
Ewen, M. E., Sluss, H. K., Whitehouse, L. L., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90723-4 · Cited by 528
The cell biology of transforming growth factor β
Barnard, J. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90013-q · Cited by 524
Incidence, aetiology and epidemiology of uterine fibroids
Okolo, S. (2008) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2008.04.002 · Cited by 515
A biochemical hallmark of apoptosis: Internucleosomal degradation of the genome
Compton, M. M. (1992) · Cancer and Metastasis Review · doi:10.1007/bf00048058 · Cited by 514
Singletary, K. W., & Gapstur, S. M. (2001) · JAMA · doi:10.1001/jama.286.17.2143 · Cited by 509
Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, H., Buchier, M., & Beger, H. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116001 · Cited by 492
Braun, L., Mead, J. E., Panzica, M., Mikumo, R., Bell, G. I., & Fausto, N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1539 · Cited by 479
Genomic Instability Induced by Ionizing Radiation
Morgan, W. F., Day, J. P., Kaplan, M. I., McGhee, E. M., & Limoli, C. L. (1996) · Radiation Research · doi:10.2307/3579454 · Cited by 478
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Hatanpaa, K. J., Burma, S., Zhao, D., & Habib, A. A. (2010) · Neoplasia · doi:10.1593/neo.10688 · Cited by 471
Goldenberg, M. M. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88288-0 · Cited by 453
Laiho, M., Saksela, O., Andreasen, P. A., & Keski-Oja, J. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2403 · Cited by 437
Asher, H. R., Schoenberg Fejzo, M., Tkachenko, A., Zhou, X., Fletcher, J. A., Weremowicz, S., Morton, C. C., & Chada, K. (1995) · Cell · doi:10.1016/0092-8674(95)90052-7 · Cited by 427
Bouche, G., Gas, N., Prats, H., Baldin, V, Tauber, J. P., Teissié, J., & Amalric, F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6770 · Cited by 426
Epidermal growth factor receptor inhibition strategies in oncology
Harari, P. M. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00600 · Cited by 423
Secondary leukemias induced by topoisomerase-targeted drugs
Felix, C. A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00139-0 · Cited by 418
Welch, D. R., Fabra, A., & Nakajima, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7678 · Cited by 392
Glycemic index in chronic disease: a review
Augustin, L., Franceschi, S., Jenkins, D., Kendall, C., & La Vecchia, C. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601454 · Cited by 390
(1992) · PubMed · Cited by 383
Collins, K., Jacks, T., & Pavletich, N. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.2776 · Cited by 380
Cao, L., Liu, X., Lin, E.-J. D., Wang, C., Choi, E. Y., Riban, V., Lin, B., & During, M. J. (2010) · Cell · doi:10.1016/j.cell.2010.05.029 · Cited by 369
The type 1 (EGFR-related) family of growth factor receptors and their ligands
Prigent, S. A., & Lemoine, N. R. (1992) · Progress in Growth Factor Research · doi:10.1016/0955-2235(92)90002-y · Cited by 369
Saksela, O., Moscatelli, D., & Rifkin, D. B. (1987) · The Journal of cell biology · doi:10.1083/jcb.105.2.957 · Cited by 367
Uterine fibroids: A clinical review
VOLLENHOVEN, B. J., LAWRENCE, A. S., & HEALY, D. L. (1990) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1990.tb01804.x · Cited by 360
Prigent, S. A., & Gullick, W. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06577.x · Cited by 359
Cosic, I. (1994) · IEEE Transactions on Biomedical Engineering · doi:10.1109/10.335859 · Cited by 337
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
Normanno, N., Bianco, C., De Luca, A., Maiello, M. R., & Salomon, D. S. (2003) · Endocrine-related cancer · doi:10.1677/erc.0.0100001 · Cited by 336
Schoop, V. M., Fusenig, N. E., & Mirancea, N. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00524.x · Cited by 333
Maa, M. C., Leu, T. H., McCarley, D. J., Schatzman, R. C., & Parsons, S. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6981 · Cited by 330
Tumor Invasion: Role of Growth Factor-Induced Cell Motility
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)61023-4 · Cited by 330
Coffey, R. J., Bascom, C. C., Sipes, N. J., Graves-Deal, R., Weissman, B. E., & Moses, H. L. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3088 · Cited by 322
Auberger, P., Falquerho, L., Contreres, J. O., Pages, G., Cam, G. L., Rossi, B., & Cam, A. L. (1989) · Cell · doi:10.1016/0092-8674(89)90098-6 · Cited by 321
Obesity and cancer: Symposium on ‘Diet and cancer’
Pischon, T., Nöthlings, U., & Boeing, H. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108006976 · Cited by 320
Nasopharyngeal carcinoma—Review of the molecular mechanisms of tumorigenesis
Chou, J., Lin, Y., Kim, J., You, L., Xu, Z., He, B., & Jablons, D. M. (2008) · Head & Neck · doi:10.1002/hed.20833 · Cited by 317
The IGF system and breast cancer.
Sachdev, D., & Yee, D. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080197 · Cited by 314
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.
Rong, S., Bodescot, M., Blair, D., Dunn, J., Nakamura, T., Mizuno, K., Park, M., Chan, A., Aaronson, S., & Vande Woude, G. F. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5152 · Cited by 312
Self-citationRegulation of Liver Growth: Protooncogenes and Transforming Growth Factors
Fausto, N., & Mead, J. E. (1990) · Pathology Reviews • 1990 · doi:10.1007/978-1-4612-0485-5_1 · Cited by 309
Physical activity and cancer etiology: associations and mechanisms
McTiernan, A., Ulrich, C., Slate, S., & Potter, J. (1998) · Cancer Causes & Control · doi:10.1023/a:1008853601471 · Cited by 302
ZD1839 (???Iressa???)*,??? as an Anticancer Agent
Baselga, J., & Averbuch, S. D. (2000) · Drugs · doi:10.2165/00003495-200060001-00004 · Cited by 301
Exercise-dependent regulation of the tumour microenvironment
Koelwyn, G. J., Quail, D. F., Zhang, X., White, R. M., & Jones, L. W. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.78 · Cited by 296
Sasaoka, T., Rose, D. W., Jhun, B. H., Saltiel, A. R., Draznin, B., & Olefsky, J. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36885-0 · Cited by 291
Coppola, D., Ferber, A., Miura, M., Sell, C., D'Ambrosio, C., Rubin, R., & Baserga, R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4588 · Cited by 284
Fan, Z., Lu, Y., Wu, X., & Mendelsohn, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47026-3 · Cited by 283
Recent advances on the role of tumor exosomes in immunosuppression and disease progression
Filipazzi, P., Bürdek, M., Villa, A., Rivoltini, L., & Huber, V. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.005 · Cited by 283
DiGiovanni, J., Kiguchi, K., Frijhoff, A., Wilker, E., Bol, D. K., Beltrán, L., Moats, S., Ramirez, A., Jorcano, J., & Conti, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3455 · Cited by 281
Transgenic Models of Tumor Development
Adams, J. M., & Cory, S. (1991) · Science · doi:10.1126/science.1957168 · Cited by 280
Heck, D. E., Laskin, D. L., Gardner, C. R., & Laskin, J. D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36601-3 · Cited by 278
Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product
Rubin, J. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90015-5 · Cited by 277
Aspirin use, cancer, and polyps of the large bowel
Suh, O., Mettlin, C., & Petrelli, N. J. (1993) · Cancer · doi:10.1002/1097-0142(19930815)72:4<1171::aid-cncr2820720407>3.0.co;2-d · Cited by 276
The growth arrest-specific gene, gas1, is involved in growth suppression
Del Sal, G. (1992) · Cell · doi:10.1016/0092-8674(92)90429-g · Cited by 275
DNA adducts, mutations and cancer
Hemminki, K. (1993) · Carcinogenesis · doi:10.1093/carcin/14.10.2007 · Cited by 275
Tzahar, E., Levkowitz, G., Karunagaran, D., Yi, L., Peles, E., Lavi, S., Chang, D., Liu, N., Yayon, A., & Wen, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31521-1 · Cited by 272
Rogina, A. (2014) · Applied Surface Science · doi:10.1016/j.apsusc.2014.01.098 · Cited by 272
Straight, S. W., Hinkle, P. M., Jewers, R. J., & McCance, D. J. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4521-4532.1993 · Cited by 271
eps15, a novel tyrosine kinase substrate, exhibits transforming activity.
Fazioli, F., Minichiello, L., Matoskova, B., Wong, W. T., & Di Fiore, P. P. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5814 · Cited by 270
Isobe, T., Okuyama, T., Toyoda, H., Komurasaki, T., Uchida, D., Takayama, Y., & Hanada, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7495 · Cited by 269
The complexity of targeting EGFR signalling in cancer: From expression to turnover
Sebastian, S., Settleman, J., Reshkin, S. J., Azzariti, A., Bellizzi, A., & Paradiso, A. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.001 · Cited by 260
Epidermal growth factor receptor: a promising target in solid tumours
Laskin, J. J., & Sandler, A. B. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.10.002 · Cited by 253
A role for TGF-beta in oligodendrocyte differentiation.
McKinnon, R. D., Piras, G., Ida, J. A., & Dubois-Dalcq, M. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.6.1397 · Cited by 248
RGS-containing RhoGEFs: the missing link between transforming G proteins and Rho?
Fukuhara, S., Chikumi, H., & Gutkind, J. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204182 · Cited by 219
Biology of Interactions: Antiepidermal Growth Factor Receptor Agents
Harari, P. M., Allen, G. W., & Bonner, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8984 · Cited by 214
Kowanetz, K., Husnjak, K., Höller, D., Kowanetz, M., Soubeyran, P., Hirsch, D., Schmidt, M. H. H., Pavelic, K., De Camilli, P., Randazzo, P. A., et al. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0683 · Cited by 128
Comparison of the Interactions of Different Growth Factors and Glycosaminoglycans
Zhang, F., Zheng, L., Cheng, S., Peng, Y., Fu, L., Zhang, X., & Linhardt, R. (2019) · Molecules · doi:10.3390/molecules24183360 · Cited by 93
Metadata
- Authors
- Aaronson, S. A.
- Venue
- Science
- Published
- 1991-11-22
- Volume
- 254
- Issue
- 5035
- Pages
- 1146-1153
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2057409901
- Cited by
- 2,028
- References
- 226
- FWCI
- 57.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.